Ropes & Gray represented LianBio on the deal. LianBio (Nasdaq: LIAN) announced it has entered into an agreement with Bristol Myers Squibb (NYSE:BMY)(BMS), whereby BMS has obtained...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised LianBio on the deal. Pfizer and LianBio announced on December 19, 2022 that Pfizer has opted in to the right to develop...
You must be a Standard 1 Year member to access this content.
Zhong Lun and Ropes & Gray advised LianBio on the deal. LianBio executed an initial public offering and listing of American depositary shares on the Nasdaq...
You must be a Standard 1 Year member to access this content.
